Towards drugs of the future: key issues in lead finding and lead optimization
by Solvay Pharmaceuticals Conference on Medicinal Chemistry, Garmisch-Partenkirchen, Germany), Kruse, C. G., (Chris G.), Timmerman, H., (Hendrick), Solvay Pharmaceuticals
fromSolvay Pharmaceuticals Conferences
Towards drugs of the future: key issues in lead finding and lead optimization
by Solvay Pharmaceuticals Conference on Medicinal Chemistry, Garmisch-Partenkirchen, Germany), Kruse, C. G., (Kruse, Chris G.), Timmerman, H., (Timmerman, Hendrick), Solvay Pharmaceuticals
fromSolvay Pharmaceuticals Conferences
Towards drugs of the future: key issues in lead finding and lead optimization
by Kruse, Chris G., Timmerman, Hendrick, Conference on Medicinal Chemistry, Garmisch-Partenkirchen, Solvay Pharmaceuticals BV, Solvay Pharmaceuticals Conference on Medicinal Chemistry, Garmisch-Partenkirchen), Solvay Pharmaceuticals Research Conference, Garmisch-Partenkirchen)
fromSolvay Pharmaceuticals Conferences
Towards drugs of the future: key issues in lead finding and lead optimization
by ProQuest (Firm), Solvay Pharmaceuticals Conference on Medicinal Chemistry, Garmisch-Partenkirchen, Germany), Kruse, C. G., (Chris G.), Timmerman, H., (Hendrick), Solvay Pharmaceuticals
fromSolvay Pharmaceuticals Conferences
Towards drugs of the future: key issues in lead finding and lead optimization
by Solvay Pharmaceuticals Conference on Medicinal Chemistry, Garmisch-Partenkirchen, Germany), Kruse, C. G., (Chris G.), Timmerman, H., (Hendrick), Solvay Pharmaceuticals
fromSolvay Pharmaceuticals Conferences
The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicina…
Towards drugs of the future: key issues in lead finding and lead optimization
by Solvay Pharmaceuticals Conference on Medicinal Chemistry, Garmisch-Partenkirchen, Germany), Kruse, C. G., (Chris G.), Timmerman, H., (Hendrick), Solvay Pharmaceuticals
fromSolvay Pharmaceuticals Conferences
The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicina…